Alto Neuroscience, Inc.
ANRO- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001999480
In the last 90 days, Alto Neuroscience, Inc. insiders filed 0 open-market purchases and 1 sale; 114 institutions reported holding it in 13F filings for Q2 2026, worth $777.6M in total; no superinvestor holds it.
Q3 2024 vs. Q2 2024
How the institutions holding Alto Neuroscience, Inc. changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Of which not filed for Q3 2024 | Q3 2024 | Change |
|---|---|---|---|---|
| Holders | 58 | 1 | 75 | +18 |
| Shares | 18.6M | 570.9K | 22.9M | +4.91M (+27.2%) |
| Value | $198.8M | $6.10M | $265.5M | +$72.8M (+37.8%) |
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (23)
Institutions that held Alto Neuroscience, Inc. at the end of Q3 2024 but not at the end of Q2 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| BlackRock, Inc. | 1,445,734 | $16.5M | 0.00% |
| Siren, L.L.C. | 391,406 | $4.48M | 0.22% |
| Avidity Partners Management LP | 240,000 | $2.75M | 0.14% |
| Schonfeld Strategic Advisors LLC | 169,801 | $1.94M | 0.02% |
| Wetherby Asset Management Inc | 84,162 | $962.8K | 0.04% |
| Ieq Capital, LLC | 65,189 | $745.8K | 0.01% |
| Wellington Management Group LLP | 60,636 | $693.7K | 0.00% |
| Allianz Asset Management GmbH | 36,900 | $422.1K | 0.00% |
| Ameriprise Financial Inc | 20,656 | $236.3K | 0.00% |
| Two Sigma Investments, LP | 12,940 | $148.0K | 0.00% |
| MetLife Investment Management | 12,783 | $146.2K | 0.00% |
| Mirae Asset Global ETFs Holdings Ltd. | 11,679 | $133.6K | 0.00% |
| Deutsche Bank AG | 11,581 | $132.5K | 0.00% |
| Jane Street Group, LLC | 10,817 | $123.7K | 0.00% |
| Rothschild Investment LLC | 2,885 | $33.0K | 0.00% |
| Tower Research Capital LLC (TRC) | 1,228 | $14.0K | 0.00% |
| CWM, LLC | 79 | $1.00K | 0.00% |
| Sterling Capital Management LLC | 41 | $469 | 0.00% |
| Lindbrook Capital, LLC | 35 | $400 | 0.00% |
| Allworth Financial LP | 17 | $195 | 0.00% |
| US Bancorp | 17 | $194 | 0.00% |
| Nisa Investment Advisors, LLC | 7 | $80 | 0.00% |
| Capital Performance Advisors LLP | 4 | $46 | 0.00% |
Sold out (5)
Institutions that held Alto Neuroscience, Inc. at the end of Q2 2024 and filed for Q3 2024 without it.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| Artal Group S.A. | 350,000 | $3.74M |
| Valor Management LLC | 157,038 | $1.68M |
| Norges Bank | 76,672 | $819.6K |
| Millennium Management LLC | 16,838 | $180.0K |
| STRS Ohio | 1,600 | $17.1K |
Not filed for Q3 2024 yet (1)
Institutions that held Alto Neuroscience, Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| BlackRock Inc. | 570,924 | $6.10M |